Herrmann R - Search Results

1

Rituximab plus gemcitabine: a therapeutic option for elderly or frail patients with aggressive non Hodgkin's lymphoma?

Wenger C, Stern M, Herrmann R, Rochlitz Ch, Pless M. Wenger C, et al. Among authors: herrmann r. Leuk Lymphoma. 2005 Jan;46(1):71-5. doi: 10.1080/10428190400007540. Leuk Lymphoma. 2005. PMID: 15621783 Clinical Trial.

2

A case of post-transplant lymphoproliferative disease presenting as CD20-expressing, Epstein-Barr-virus positive Hodgkin lymphoma.

Stern M, Herrmann R, Rochlitz C, Dirnhofer S, Pless M. Stern M, et al. Among authors: herrmann r. Eur J Haematol. 2005 Mar;74(3):267-70. doi: 10.1111/j.1600-0609.2004.00398.x. Eur J Haematol. 2005. PMID: 15693799

3

Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter study.

Pless M, Belhadj K, Menssen HD, Kern W, Coiffier B, Wolf J, Herrmann R, Thiel E, Bootle D, Sklenar I, Müller C, Choi L, Porter C, Capdeville R. Pless M, et al. Among authors: herrmann r. Clin Cancer Res. 2004 Feb 15;10(4):1299-305. doi: 10.1158/1078-0432.ccr-0977-03. Clin Cancer Res. 2004. PMID: 14977828 Clinical Trial.

4

Vinorelbine plus low-dose cisplatinum with concomitant radiotherapy for the treatment of locally advanced or inoperable non-metastasized non-small-cell lung cancer (stage I-IIIB): a phase II study.

Winterhalder R, Deschler-Marini S, Landmann C, Kann R, Passweg J, Herrmann R, Pless M. Winterhalder R, et al. Among authors: herrmann r. Radiother Oncol. 2004 Dec;73(3):321-4. doi: 10.1016/j.radonc.2004.06.009. Radiother Oncol. 2004. PMID: 15588877 Clinical Trial.

5

Combined chemoradiotherapy with daily low-dose cisplatin in locally advanced inoperable non-small cell lung cancer.

Biedermann B, Landmann C, Kann R, Passweg J, Solèr M, Lohri A, Rochlitz C, Herrmann R, Pless M. Biedermann B, et al. Among authors: herrmann r. Radiother Oncol. 2000 Aug;56(2):169-73. doi: 10.1016/s0167-8140(00)00203-6. Radiother Oncol. 2000. PMID: 10927135

6

Toxic encephalopathy induced by capecitabine.

Niemann B, Rochlitz C, Herrmann R, Pless M. Niemann B, et al. Among authors: herrmann r. Oncology. 2004;66(4):331-5. doi: 10.1159/000078335. Oncology. 2004. PMID: 15218302

7

Overview of monoclonal antibodies in cancer therapy: present and promise.

Stern M, Herrmann R. Stern M, et al. Among authors: herrmann r. Crit Rev Oncol Hematol. 2005 Apr;54(1):11-29. doi: 10.1016/j.critrevonc.2004.10.011. Crit Rev Oncol Hematol. 2005. PMID: 15780905 Review.

8

Significant progress in palliative treatment of non-small cell lung cancer in the past decade.

Waechter F, Passweg J, Tamm M, Brutsche M, Herrmann R, Pless M. Waechter F, et al. Among authors: herrmann r. Chest. 2005 Mar;127(3):738-47. doi: 10.1378/chest.127.3.738. Chest. 2005. PMID: 15764752

9

Targeted radiotherapy for small cell lung cancer using 90Yttrium-DOTATOC, an Yttrium-labelled somatostatin analogue: a pilot trial.

Pless M, Waldherr C, Maecke H, Buitrago C, Herrmann R, Mueller-Brand J. Pless M, et al. Among authors: herrmann r. Lung Cancer. 2004 Sep;45(3):365-71. doi: 10.1016/j.lungcan.2004.02.020. Lung Cancer. 2004. PMID: 15301877 Clinical Trial.

10

A phase I study with oral SU5416 in patients with advanced solid tumors: a drug inducing its clearance.

Salzberg M, Pless M, Rochlitz C, Ambrus K, Scigalla P, Herrmann R. Salzberg M, et al. Among authors: herrmann r. Invest New Drugs. 2006 Jul;24(4):299-304. doi: 10.1007/s10637-005-4061-z. Invest New Drugs. 2006. PMID: 16237511 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,049 results

Search Page

Filters